Results 121 to 130 of about 244,299 (237)
Provider reported challenges with completing death certificates: A focus group study demonstrating potential sources of error. [PDF]
Morgan A+5 more
europepmc +1 more source
ABSTRACT Background Up to 50% of patients with ST‐segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (pPCI) develop coronary microvascular dysfunction (CMD). Aims This study aims to assess whether a prothrombotic state of coronary blood, defined by thromboelastography (TEG), is associated with post ...
Roberto Scarsini+15 more
wiley +1 more source
Does the Application of International Classification of Disease Codes for the Cause of Death on Death Certificates Reduce Garbage Codes? [PDF]
Park S, Kim SH.
europepmc +1 more source
Synthesis and Biological Evaluation of Bicyclic Pyrazolines with Promising Antimicrobial Activities
Continuous flow technology is exploited for the generation of bicyclic pyrazolines via photo‐click reactions. These heterocyclic species contain a valuable 3D scaffold along with a polar succinimide moiety. Subsequent antimicrobial testing reveals that halogenated moieties such as chlorine atoms and trifluoromethoxy groups enhance the potency of these ...
Debora Caviglia+4 more
wiley +1 more source
Characteristics of deceased and quality of death certificates for cases subjected to Indonesia's management of the dead protocol for bodies with COVID-19. [PDF]
Meilia PDI+10 more
europepmc +1 more source
NCHS data on drug-poisoning deaths [PDF]
Poisoning is the leading cause of injury death in the United States. Drugs\ue2\u20ac\u201dboth pharmaceutical and illicit\ue2\u20ac\u201dcause the vast majority of poisoning deaths.NCHS uses the National Vital Statistics System (NVSS) to monitor deaths ...
core
Although attractive for relevance to real‐world scenarios, real‐world data (RWD) is typically used for drug repurposing and not therapeutic target discovery. Repurposing studies have identified few effective options in neurological diseases such as the rare disease, amyotrophic lateral sclerosis (ALS), which has no disease‐modifying treatments ...
Mohammadali Alidoost+9 more
wiley +1 more source
Evaluation of CYP2C19 Clinical Decision Support Alerts to Guide P2Y12 Inhibitor Prescribing
P2Y12 inhibitor selection involves numerous factors, including CYP2C19 genetics, since evidence demonstrates reduced clopidogrel efficacy in patients with decreased or no function CYP2C19 variants. In 2020, Indiana University health embedded interruptive clinical decision support (CDS) alerts in the electronic health record (EHR) to recommend ...
Ashley N. Springer+14 more
wiley +1 more source